OSU MedNet21

This talk will focus on a review of guideline-based risk assessment for atherosclerotic cardiovascular disease. We will define risk severity for both primary and secondary prevention with the help of some risk calculator tools. We will define risk-enhancing factors for cardiovascular disease and their appropriate utilization, with special focus on coronary artery calcium score and lipoprotein(a).

Link to transcript

This activity will review the epidemiology, staging, and initial treatment of lung cancer. In addition, the approach to the incidental pulmonary nodule will be discussed.

Link to transcript

This program will discuss Breast Cancer Screening.  By participating in this activity, the learner will gain an understanding of the importance of breast cancer screening and how best to approach and utilize breast cancer screening tools. The learner will gain a deeper understanding of the methods and approaches available for breast cancer screening and how to choose the best screening paradigm for different patient groups.

Link to transcript

This program will discuss Food as Medicine. Learners will describe how a poor diet contributes to disease and mortality and identify mechanisms for how intensive dietary change can prevent, treat and potentially reverse disease. Learners will be able to name the components of a healthiest diet and how lifestyle medicine and obesity medicine can be used as a framework to approach nutrition.

Link to transcript

This program will discuss Harm Reduction Strategies for People Who Use Drugs.  Learners can expect to learn about harm reduction, which is a philosophy, practice and approach to working with people who use drugs that focuses on prevention, risk-reduction and empowerment to let patients lead healthier and self-directed lives.

Link to transcript

This program will go over screening guidelines for preventative health. The program will focus on non-malignant conditions and will cover the entire age span from pediatric to adult patients. The first section will review evidence and grading of recommendations. Then the program will go through pediatric recommendations grouping them into categories. The second half of the program will focus on adult screening guidelines. Before the conclusions, there will also be a discussion of some of the screening tips and pitfalls.

Link to transcript

Learners will be given the definition of refractory depression and learn how to identify refractory depression in their patient population. Next the presentation will go through algorithm of depression treatment followed by explanation of interventional depression treatment options as well as second line medications that can be used.

Link to transcript

This program will cover the topic of inpatient use of Buprenorphine for pain management. The presenters will first review the pharmacology of Buprenorphine including its mechanism of action and safety profile. They will discuss practical applications for using Buprenorphine for pain management as well as common dosing and routes of administration. They will use case studies to illustrate use cases scenarios and finally will also review limitations and logistics for coverage and continuation of these medications beyond the hospital setting.

Link to transcript

This program will give an overview of asthma for patients twelve and up. The program will start with overview of asthma including the pathophysiology of disease. Then it will review two of the newer asthma treatment concepts: Anti-inflammatory Reliever (AIR) therapy, and Maintenance and Reliever Therapy (MART). Finally, the presenter will discuss difficult to treat asthma as well as severe asthma.

Link to transcript

This program will discuss Artificial Intelligence in Medicine. After this presentation, learners should have a basic understanding of the structure of artificial intelligence research questions, and the types of clinical dilemmas that have utilized AI across medicine.

Link to transcript